Let’s say it’s 2036, and scientists are working on a new class of drugs. Today, for instance, pharmaceutical companies use ...

Every time our body encounters a new disease-causing agent, a crucial defense system called adaptive immunity comes into play ...

Scientists have long known that cellular membranes vary in thickness, but measuring those differences inside actual cells has ...

UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes ...

Data update from the ongoing Phase 1b/2 study of muzastotug + pembrolizumab in 3L+ MSS CRC patients remains on track for Q1 ...

The discovery that tissues use electricity to expel unhealthy cells is part of a surge of renewed interest in the currents ...

When the four-member crew of Axiom-2 launched into space in May 2023, their 10-day mission was chock full of experiments ...

Sickle cell disease is caused by a single genetic mutation that alters the shape of red blood cells. While the condition ...

In an interview with Targeted Oncology, George Mulligan, PhD, discussed the key takeaways from analysis of the Immune Atlas ...

Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, releases the following letter to ...